Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE)
- 1 May 1993
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 68 (1-2) , 131-144
- https://doi.org/10.1016/0378-4274(93)90126-i
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A physiologically based pharmacokinetic and pharmacodynamic model to describe the oral dosing of rats with ethyl acrylate and its implications for risk assessmentToxicology and Applied Pharmacology, 1992
- Uncertainties in Pharmacokinetic Modeling for Perchloroethylene. I. Comparison of Model Structure, Parameters, and Predictions for Low‐Dose Metabolism Rates for Models Derived by Different AuthorsRisk Analysis, 1990
- Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxaneToxicology and Applied Pharmacology, 1990
- Mechanism of transport and distribution of organic solvents in bloodToxicology and Applied Pharmacology, 1990
- Precision and sensitivity of pharmacokinetic models for cancer risk assessment: Tetrachloroethylene in mice, rats, and humansToxicology and Applied Pharmacology, 1990
- Evaluation of uncertainty in input parameters to pharmacokinetic models and the resulting uncertainty in outputToxicology Letters, 1989
- Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissuesToxicology and Applied Pharmacology, 1989
- Physiologically based pharmacokinetics and the risk assessment process for methylene chlorideToxicology and Applied Pharmacology, 1987
- Experimental human exposures to tetrachloroethylene vapor and elimination in breath after inhalationAihaj Journal, 1976
- Experimental HumanArchives of environmental health, 1970